Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma.
about
NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer ImmunotherapyRadiation for Awakening the Dormant Immune System, a Promising Challenge to be ExploredCombining radiotherapy and cancer immunotherapy: a paradigm shiftThe optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translationEZH2 as a mediator of treatment resistance in melanomaCirculating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.Combinations of immunotherapy and radiation in cancer therapy.Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer.Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsetsRadiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice.Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor AntigenMaximizing tumor immunity with fractionated radiation.Role of T lymphocytes in tumor response to radiotherapy.Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.Radiation as an immunological adjuvant: current evidence on dose and fractionation.A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment.Radiotherapy: Changing the Game in Immunotherapy.Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling.Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.Systemic effects of local radiotherapy.Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.A Century of Radiation Therapy and Adaptive ImmunityThe confluence of stereotactic ablative radiotherapy and tumor immunology.Radiation and inflammation.In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatmentTowards precision radiotherapy for use with immune checkpoint blockers.Combining radiotherapy with immunotherapy: the past, the present and the future.A perspective on the impact of radiation therapy on the immune rheostat.Emerging Opportunities and Challenges in Cancer Immunotherapy.The changing paradigm of tumour response to irradiation.Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.Radiation therapy to convert the tumor into an in situ vaccine.The Future of Radiobiology.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Radiation and Anti-Cancer Vaccines: A Winning Combination.Using immunotherapy to boost the abscopal effect.
P2860
Q26797345-150475CD-C36B-4DBA-BB5A-454A2D9B14EDQ26865395-B998C5D3-89CC-4E2D-B4C1-1270EEA83687Q27021428-A96F78A4-F2E3-42DD-B94E-2BA77BF98BCDQ27024106-ED8DF6E0-E7C6-4500-8B3A-143C79963C50Q28074492-41B342CD-F7C7-4912-99BD-D481B6A1BFDBQ33816412-B7B9FFDB-30A5-4F98-9065-7C02625E3CE2Q33952083-B09BEFD1-9C16-4D2A-8308-34512711E28DQ34298754-C76B9630-C821-4D80-BDC2-4A1CCF5D62E3Q34582640-D8AED0A5-A7DF-4E50-9F93-E2117603F731Q35061159-4C33E122-4299-46F3-B05F-7D37E5B7BE39Q35083126-5BDEBFB5-EEFF-4F1C-B639-0FA8A01B7EB6Q35088240-276AD1B6-B428-4A5B-86ED-3EF65BB62C55Q35328111-79252D79-B314-45A5-AA08-E7571206C23DQ35916615-3F864E08-EAA9-4F20-9A2D-30E408E0A513Q36186619-D21C2560-D5A5-445F-A649-B61AB0AE87A6Q36224057-DF114B66-7593-4859-9D4A-A637C5140723Q36347177-70659DD5-1755-4125-A12F-078A29FA3A10Q36699077-E4EF324B-9A4A-48AD-A3CF-99355B0CCB01Q36746004-C7092DF4-EBCE-4618-BA5E-4469A403B922Q37351338-FDB44ACF-7426-4FC5-A0CB-7C052AD83005Q37379390-191BB7F6-20D3-4C6B-B9CC-21E0F02E9CA7Q37507341-4009C384-1F52-4ADB-91CD-8F15C9BAD1EFQ37518395-AB521CF3-8FFC-49C3-BB44-A628FC06F9B0Q37539309-40F0C1AD-166A-4311-8D9A-9FF6E6ADF712Q37666685-F2062E02-A3F3-4609-90F9-8CA5F6DE0C6AQ37747153-9FB51531-FCBC-42BF-8E2B-C40B7EB82A46Q37967688-8055F937-87FC-4324-AF0F-9AD22D1E0175Q38284081-97C408BD-630F-41AC-A876-F3312C03F1EAQ38543250-AF1B47FA-9534-4E02-9931-303D5112953AQ38656599-2412F683-26B8-49F2-8D77-5FCA8CA9D8DBQ38679418-56F432BE-9E13-44B5-833F-081A5AF665D6Q38679488-94AB8C81-7893-4E95-8E66-258EB3BBE6CCQ38809772-92DC8B62-B3F5-4D5D-8F20-9D8B88E9240EQ38896870-ABE6DED4-45B0-4417-B879-A57E5949277FQ41143314-975BE5DE-CF93-4346-A6B7-7EBD978C58B2Q42270394-61D888A6-7B82-49E5-A7C0-9B56F3511082Q46136392-54A1426C-1AF8-46C1-A500-42B0CC48496DQ46721978-E67EB468-9970-40AB-A48A-E425BA39C7FEQ47547584-C034453C-5642-4B60-891C-467CA34305A3Q49958115-099BAD29-AB73-40A0-90CF-E32CDAE287C2
P2860
Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Effect of host immune capabili ...... lity of a murine fibrosarcoma.
@en
type
label
Effect of host immune capabili ...... lity of a murine fibrosarcoma.
@en
prefLabel
Effect of host immune capabili ...... lity of a murine fibrosarcoma.
@en
P2093
P1476
Effect of host immune capabili ...... lity of a murine fibrosarcoma.
@en
P2093
P304
P407
P577
1979-11-01T00:00:00Z